NewAmsterdam Pharma Company N.V. (NAMS)

NASDAQ: NAMS · Real-Time Price · USD

34.24

-0.65 (-1.86%)

At close: Feb 11, 2026, 4:00 PM EST

34.31

+0.07 (0.20%)

After-hours: Feb 11, 2026, 4:13 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Transformative Therapies for Cardio-metabolic Diseases	45.56M
Transformative Therapies for Cardio-metabolic Diseases Growth	223.37%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Italy	45.56M
Italy Growth	223.37%